Thus, we conclude that both the rs2853669 variant (the co-target of E2F1 and ETS2) and −124C > T mutation (the ETS2 target) are involved in the modulation of methylation at the TERT promoter and further increased the TERT expression in HCC cells. The gene discussed is E2F1; the disease is hepatocellular carcinoma.